Login
Toggle navigation
Videos
Categories
Trending
A company introduction movie for SAMICK THK CO., LTD., part of the Korean SAMICK THK Group.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ju-Wan Jin is President/Co-CEO at Samick Thk Co Ltd.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
"Transforming Corporate Culture and Leadership: Insights from Dimensional Fund Advisors Co-CEO Dave Butler on Storytelling, Hiring Practices, and Empowering Junior Talent"
00:10:00
Angi CEO Oisin Hanrahan on Quarterly Earnings and Market Trends | Oisin Hanrahan, CEO, Angi Inc.
00:10:00
Personalized Financial Guidance: Local, Fiduciary, and Holistic Support
00:10:00
Demystifying Finance Industry Designations: CFP®, CFA, and CPA Explained | Elizabeth Hutton - VICE PRESIDENT, FINANCIAL PLANNER of Howe & Rusling, Inc.
00:00:00
SenzaGen presentation - Peter Nählstedt President and CEO, SenzaGen
00:10:00
Carson Block, founder of Muddy Waters Research, joins 'Closing Bell' to explain why his firm began investigating Hannon Armstrong's financial practices.
00:10:00
Replay: Gibson Dunn Webinar | The Lawyer Portal | Barbara L. Becker - Chair & Managing Partner of gibson dunn
00:10:00
Accel is a leading venture capital firm that has invested in over 300 companies|Arthur Patterson,Retired Founding Partner,Accel
00:10:00
John W. Rogers, Jr. on Finding Value in Volatility at Bloomberg Invest
00:10:00
Ulrika Jonsson on AI Integration and Profitability at Brilliant Future | Ulrika Jonsson, CEO, Brilliant Future AB.
00:10:00
ACEN CEO Eric Francia provides insights on the renewable energy market in the Philippines.
00:10:00
Insights on Navigating Macroeconomic Challenges and Building Strong Industry Relationships